Angiogenesis and Tissue Engineering Research
Abstract
Centers on the development of new medical therapies and regenerative medicine approaches for the treatment of injured soldiers, and the improvement of the overall health and performance of military personnel. Over the past year we designed to develop aerosol therapies to save lives in patients with pulmonary edema and Acute Respiratory Distress Syndrome (ARDS; we evaluated the anti-malarial activity of an oral angiogenesis inhibitor developed in past grant funding periods, called Lodamin, that is a methionine aminopeptidases 2 (MetAP2)inhibitor; and, we developed new microsystems technologies to harvest rare circulating stem cells for tissue engineering applications, such as blood vessel precursor cells for tissue revascularization.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2010
- Accession Number
- ADA524972
Entities
People
- Donald E. Ingber
- Joyce Bischoff
- Mark Puder